As shown in Figure 1, B16 tumor resistant animals had developed B16 specific cellular immune responses (Figure 1A and 1B), and CT26 tumor resistant animals had developed CT26 specific cellular immune responses (Figure 1C and 1D). The gene discussed is DDX53; the disease is neoplasm.